Growth Metrics

Idexx Laboratories (IDXX) Non-Current Deferred Tax Liability (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Non-Current Deferred Tax Liability data on record, last reported at $3.7 million in Q3 2025.

  • For Q3 2025, Non-Current Deferred Tax Liability fell 34.18% year-over-year to $3.7 million; the TTM value through Sep 2025 reached $3.7 million, down 34.18%, while the annual FY2024 figure was $132.2 million, 18.73% up from the prior year.
  • Non-Current Deferred Tax Liability reached $3.7 million in Q3 2025 per IDXX's latest filing, up from $2.1 million in the prior quarter.
  • Across five years, Non-Current Deferred Tax Liability topped out at $132.2 million in Q4 2024 and bottomed at $2.1 million in Q2 2025.
  • Average Non-Current Deferred Tax Liability over 5 years is $21.2 million, with a median of $8.9 million recorded in 2021.
  • Peak YoY movement for Non-Current Deferred Tax Liability: tumbled 91.3% in 2021, then soared 1266.13% in 2023.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $8.9 million in 2021, then decreased by 8.79% to $8.2 million in 2022, then skyrocketed by 1266.13% to $111.3 million in 2023, then rose by 18.73% to $132.2 million in 2024, then tumbled by 97.18% to $3.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Deferred Tax Liability were $3.7 million in Q3 2025, $2.1 million in Q2 2025, and $8.1 million in Q1 2025.